rs74315305
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000271651.8(CTSK):c.236G>A(p.Gly79Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G79R) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000271651.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSK | NM_000396.4 | c.236G>A | p.Gly79Glu | missense_variant | 3/8 | ENST00000271651.8 | NP_000387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSK | ENST00000271651.8 | c.236G>A | p.Gly79Glu | missense_variant | 3/8 | 1 | NM_000396.4 | ENSP00000271651 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Pyknodysostosis Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1999 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 03, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 23, 2024 | Variant summary: CTSK c.236G>A (p.Gly79Glu) results in a non-conservative amino acid change located in the Cathepsin propeptide inhibitor domain (IPR013201) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251314 control chromosomes. c.236G>A has been reported in the literature in individuals affected with Pyknodysostosis (examples: Haagerup_2000, Ho_1999, Hou_1999, Sait_2021). These data indicate that the variant is likely to be associated with disease. Multiple publications report experimental evidence evaluating an impact on protein function (Hou_1999, Roy_2018). The most pronounced variant effect results in the absence of protease activity. The following publications have been ascertained in the context of this evaluation (PMID: 10878663, 10491211, 10074491, 30199612, 33945887). ClinVar contains an entry for this variant (Variation ID: 8424). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at